IMI (LON:IMI) Insider Purchases £153.90 in Stock

Key Points

• IMI insider Roy Twite bought 5 shares at GBX 3,078 each, totaling £153.90, following similar purchases in August and September.
• IMI shares fell 0.7% to GBX 3,004, while the company reported quarterly EPS of GBX 63.40 and analysts forecast full-year EPS of GBX 137.97.
• Analyst sentiment remains positive, with five Buy ratings and one Hold; the stock has a consensus “Moderate Buy” rating and a GBX 3,171.67 price target.

IMI plc (LON:IMI - Get Free Report) insider Roy Twite bought 5 shares of the stock in a transaction on Tuesday, October 13th. The stock was purchased at an average price of GBX 3,078 per share, for a total transaction of £153.90.

Roy Twite also recently made the following trade(s):

• On Tuesday, September 8th, Roy Twite bought 5 shares of IMI stock. The stock was purchased at an average cost of GBX 3,090 per share, for a total transaction of £154.50.
• On Tuesday, August 11th, Roy Twite purchased 5 shares of IMI stock. The shares were purchased at an average cost of GBX 3,098 per share, with a total value of £154.90.

IMI Stock Down 0.7%

Shares of IMI stock traded down GBX 22 during trading on Wednesday, hitting GBX 3,004. 695,048 shares of the stock traded hands, compared to its average volume of 7,805,541. The stock has a market cap of £7.05 billion, a P/E ratio of 22.14, a PEG ratio of 1.12 and a beta of 1.04. The company has a debt-to-equity ratio of 80.30, a quick ratio of 0.80 and a current ratio of 1.30. IMI plc has a twelve month low of GBX 1,802.19 and a twelve month high of GBX 3,848. The company has a fifty day moving average price of GBX 3,081.41 and a two-hundred day moving average price of GBX 2,920.05.

IMI (LON:IMI - Get Free Report) last released its quarterly earnings data on Friday, July 31st. The company reported GBX 63.40 EPS for the quarter. IMI had a return on equity of 32.41% and a net margin of 14.09%. Equities research analysts predict that IMI plc will post 137.97 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on IMI shares. Royal Bank Of Canada restated a "sector perform" rating and set a GBX 2,850 price target on shares of IMI in a report on Friday, July 31st. Berenberg Bank reiterated a "buy" rating and issued a GBX 3,300 price objective on shares of IMI in a report on Wednesday, August 5th. JPMorgan Chase & Co. upped their price objective on shares of IMI from GBX 3,050 to GBX 3,300 and gave the stock an "overweight" rating in a report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft increased their target price on shares of IMI from GBX 3,250 to GBX 3,440 and gave the stock a "buy" rating in a research report on Monday, August 3rd. Finally, Jefferies Financial Group restated a "buy" rating and set a GBX 3,380 target price on shares of IMI in a report on Friday, July 31st. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 3,171.67.

IMI Company Profile

IMI is a global leader in fluid and motion control, engineering bespoke solutions that enhance safety, productivity and sustainability across critical industries in energy, automation and healthcare. We work in close partnership with customers to design, build and service high-performance valves, actuators and control systems that solve complex engineering challenges. Our solutions are a small part of our customers' systems – but they play a critical role in how those systems perform. By combining deep technical expertise with real customer insight, we deliver solutions that are precisely engineered for impact. Through our One IMI model, we combine commercial excellence, market-led innovation and continuous improvement to scale what works across the business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.